Skip to content
AwardedSpainGoods

Suministro de 10.000 envases de Baloxavir (Xofluza) para la Reserva Estratégica Nacional

Published
Published 27 May 2026

Overview

The National Health Management Institute (INGESA) has procured 10,000 units of Baloxavir (Xofluza) antiviral medication for the National Strategic Health Reserve as required by Spanish regulations. The contract, valued at €433,000, was awarded to Roche Farma, S.A. on 17 April 2026 and is now complete.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
27 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€433,000
Award date
17 April 2026
Winner
  • Roche Farma, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 May 2026

Contracting authority

  • Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)

    Procuring entity

    Madrid, Spain

    ID_PLATAFORMA: 10000440058861

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de 10.000 envases de Baloxavir (Xofluza) para la Reserva Estratégica Nacional — won by Roche Farma, S.A. — Skim